Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Biotech ETF (BBH)

Delayed Data
As of Sep 18
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVISä US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.


1 month+7.66% 3 years+8.14%
3 months+11.33% 5 years+20.15%
1 year+15.02% Since inception+26.36%
Data through 09/19/2017

Quote Details

Previous close$134.10
Open day’s range-- – --
Net asset value (NAV)134.08 (09/18/2017)
Daily volume0
Average volume (3 months)31,072
Data as of 09/18/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+20.15%+17.39%
Expense Gross exp ratio0.40%1.33%
Risk 5 year sharpe ratio1.011.13
Net assets$716.3M$3.1B
Average market cap$38.6B$32.0B
Average P/E21.822.7
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
CELG Celgene11.12%
AMGN Amgen11.12%
GILD Gilead Sciences11.06%
AGN Allergan6.65%
BIIB Biogen6.24%
ALXN Alexion Pharmaceuticals Inc5.68%
VRTX Vertex Pharmaceuticals Inc5.13%
REGN Regeneron Pharmaceuticals4.60%
INCY Incyte Corp4.58%
ILMN Illumina Inc4.57%